BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo J, Zhao X, Tan Z, Su Z, Meng F, Zhang M. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions. Cytotherapy. 2013;15:649-662. [PMID: 23415919 DOI: 10.1016/j.jcyt.2013.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J Stem Cells 2015; 7(4): 776-788 [PMID: 26029348 DOI: 10.4252/wjsc.v7.i4.776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Krylova TA, Musorina AS, Zenin VV, Yakovleva TK, Poljanskaya GG. A comparative analysis of mesenchymal stem-cell lines derived from bone marrow and limb muscle of early human embryos. Cell Tiss Biol 2014;8:441-53. [DOI: 10.1134/s1990519x14060042] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 Du T, Zhu YJ. The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells. Mediators Inflamm 2014;2014:261697. [PMID: 24839354 DOI: 10.1155/2014/261697] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
4 Uchida N, Kumagai N, Kondo Y. Application of Muse Cell Therapy for Kidney Diseases. Adv Exp Med Biol 2018;1103:199-218. [PMID: 30484231 DOI: 10.1007/978-4-431-56847-6_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tögel FE, Bonventre JV. Multipotent mesenchymal stromal cells protect against kidney injury. Cytotherapy 2013;15:629-31. [PMID: 23643304 DOI: 10.1016/j.jcyt.2013.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Ahmadi A, Rad NK, Ezzatizadeh V, Moghadasali R. Kidney Regeneration: Stem Cells as a New Trend. CSCR 2020;15:263-83. [DOI: 10.2174/1574888x15666191218094513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zilberman-Itskovich S, Efrati S. Mesenchymal Stromal Cell Uses for Acute Kidney Injury-Current Available Data and Future Perspectives: A Mini-Review. Front Immunol 2020;11:1369. [PMID: 32793191 DOI: 10.3389/fimmu.2020.01369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Murray PA, Woolf AS. Using stem and progenitor cells to recapitulate kidney development and restore renal function. Curr Opin Organ Transplant 2014;19:140-4. [PMID: 24480967 DOI: 10.1097/MOT.0000000000000052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
9 Večerić-Haler Ž, Cerar A, Perše M. (Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity. Stem Cells Int 2017;2017:7304643. [PMID: 29379525 DOI: 10.1155/2017/7304643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
10 Torres Crigna A, Daniele C, Gamez C, Medina Balbuena S, Pastene DO, Nardozi D, Brenna C, Yard B, Gretz N, Bieback K. Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. Front Med (Lausanne) 2018;5:179. [PMID: 29963554 DOI: 10.3389/fmed.2018.00179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
11 Liu P, Feng Y, Chen X, Wang G, Nawaz I, Hu L, Zhao L. Paracrine action of human placental trophoblast cells attenuates cisplatin-induced acute kidney injury. Life Sci 2019;230:45-54. [PMID: 31125561 DOI: 10.1016/j.lfs.2019.05.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Park JH, Jang HR, Kim DH, Kwon GY, Lee JE, Huh W, Choi SJ, Oh W, Oh HY, Kim YG. Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. Am J Physiol Renal Physiol 2017;313:F984-96. [PMID: 28356286 DOI: 10.1152/ajprenal.00097.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
13 Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal Kidney Cells Can Ameliorate Ischemic Acute Renal Failure in Rats through Their Anti-Inflammatory, Anti-Apoptotic and Anti-Oxidative Effects. PLoS One 2015;10:e0131057. [PMID: 26086475 DOI: 10.1371/journal.pone.0131057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
14 Bobkov D, Polyanskaya A, Musorina A, Lomert E, Shabelnikov S, Poljanskaya G. Replicative senescence in MSCWJ-1 human umbilical cord mesenchymal stem cells is marked by characteristic changes in motility, cytoskeletal organization, and RhoA localization. Mol Biol Rep 2020;47:3867-83. [PMID: 32372170 DOI: 10.1007/s11033-020-05476-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Saat TC, van den Akker EK, IJzermans JN, Dor FJ, de Bruin RW. Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation? J Transl Med 2016;14:20. [PMID: 26791565 DOI: 10.1186/s12967-016-0767-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]